Skip to content
Disclosery

13F-HR filed by CROSSPOINT FINANCIAL, LLC

CROSSPOINT FINANCIAL, LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-10, with 10 holding rows worth $9,828,839.

Accession
0001085146-23-003241
Filer
CIK 1927769
Filed
2023-08-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 10 entries on the cover page, a total value of $9,828,839 stated on the cover page (in dollars after the unit check, H1), rows summing to $9,828,839 with VALUE read as dollars as filed, 13F file number 028-22861. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Berkshire Hathaway Inc084670702COM8,605$2,934,305dollars as filed
ETF SER SOLUTIONS26922A289DEFIANCE SPACE A68,581$2,308,652dollars as filed
VANECK ETF TRUST92189H607OIL SERVICES ETF4,589$1,319,796dollars as filed
iShares Cybersecurity and Tech ETF46435U135CYBERSECURITY34,035$1,287,195dollars as filed
FIRST TR EXCHNG TRADED FD VI33740U844FT VEST U.S23,050$771,023dollars as filed
iShares Gold Trust464285204COM20,042$729,331dollars as filed
META PLATFORMS INC CL A30303M102COM1,085$311,374dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock12,054$105,473dollars as filed
ALLOGENE THERAPEUTICS INC019770106COM12,000$59,640dollars as filed
MICROVAST HOLDINGS INC59516C114*W EXP 07/23/20210,000$2,050dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-23-003241this filing2023-08-10acceptance time not in the bulk data set